KIDNEY TRANSPLANT FAILURE AND REJECTION
Clinical trials for KIDNEY TRANSPLANT FAILURE AND REJECTION explained in plain language.
Never miss a new study
Get alerted when new KIDNEY TRANSPLANT FAILURE AND REJECTION trials appear
Sign up with your email to follow new studies for KIDNEY TRANSPLANT FAILURE AND REJECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug could change kidney transplants forever
Disease control Not yet recruitingThis study tests a new medicine called TNX-1500 in 5 people who get a kidney transplant. The goal is to see if it is safe and can help prevent the body from rejecting the new kidney. Participants will be monitored for one year after their transplant.
Matched conditions: KIDNEY TRANSPLANT FAILURE AND REJECTION
Phase: PHASE2 • Sponsor: Ayman Al Jurdi, MD • Aim: Disease control
Last updated May 17, 2026 04:09 UTC
-
Light therapy and donor cells may help kidney transplants last longer
Disease control Not yet recruitingThis early-stage trial tests whether giving kidney transplant recipients a special infusion of their donor's treated cells, followed by regular light-based therapy, can safely reduce the risk of organ rejection. About 24 adults with kidney failure receiving a first transplant fro…
Matched conditions: KIDNEY TRANSPLANT FAILURE AND REJECTION
Phase: PHASE1 • Sponsor: Northwestern University • Aim: Disease control
Last updated May 11, 2026 20:52 UTC